0000917491-20-000027 | 10-Q | XBRL Viewer

Print Document View Excel Document

Cover page - shares	3 Months Ended
Cover page - shares	Mar. 31, 2020	Apr. 24, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Mar. 31, 2020
Entity File Number	0-23081
Entity Registrant Name	FARO TECHNOLOGIES, INC
Entity Central Index Key	0000917491
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Incorporation, State or Country Code	FL
Entity Tax Identification Number	59-3157093
Entity Address, Address Line One	250 Technology Park,
Entity Address, City or Town	Lake Mary,
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32746
City Area Code	407
Local Phone Number	333-9911
Title of 12(b) Security	Common Stock, par value $.001
Trading Symbol	FARO
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		17,719,333

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 157,240	$ 133,634
Short-term investments	15,955	24,870
Accounts receivable, net	58,834	76,162
Inventories, net	55,044	58,554
Prepaid expenses and other current assets	21,237	28,996
Total current assets	308,310	322,216
Non-current assets:
Plant and equipment, net	24,515	26,954
Operating lease right-of-use asset	16,534	18,418
Goodwill	48,661	49,704
Intangible assets, net	13,820	14,471
Service and sales demonstration inventory, net	34,355	33,349
Deferred income tax assets, net	21,036	18,766
Other long-term assets	2,818	2,964
Total assets	470,049	486,842
Current liabilities:
Accounts payable	11,396	13,718
Accrued liabilities	44,360	38,072
Income taxes payable	3,826	5,182
Lease liability	5,947	6,674
Total current liabilities	106,205	105,965
Unearned service revenues - less current portion	19,985	20,578
Lease liability - less current portion	12,745	13,698
Deferred income tax liabilities	173	357
Income taxes payable - less current portion	13,177	13,177
Other long-term liabilities	974	1,075
Total liabilities	153,259	154,850
Commitments and contingencies - See Note 14
Shareholders’ equity:
Common Stock, Value, Issued	19	19
Additional paid-in capital	270,940	267,868
Retained earnings	98,056	112,879
Accumulated other comprehensive loss	(21,177)	(17,399)
Treasury Stock, Value	(31,048)	(31,375)
Total shareholders’ equity	316,790	331,992
Total liabilities and shareholders’ equity	470,049	486,842
Current portion of unearned service revenues
Current liabilities:
Current portion of unearned service revenues	38,561	39,211
Customer deposits	38,561	39,211
Customer deposits
Current liabilities:
Current portion of unearned service revenues	2,115	3,108
Customer deposits	$ 2,115	$ 3,108

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	19,116,870	17,718,179
Common stock, shares outstanding (in shares)	18,988,379	17,576,618
Treasury stock, shares (in shares)	1,398,691	1,411,761

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Sales	$ 79,515	$ 93,617
Cost of Sales	35,642	40,598
Gross Profit	43,873	53,019
Operating Expenses
Selling, general and administrative	36,324	41,020
Research and development	10,415	11,641
Restructuring costs	13,688	0
Total operating expenses	60,427	52,661
(Loss) income from operations	(16,554)	358
Other (income) expense
Interest expense (income), net	34	(144)
Other expense, net	473	195
(Loss) income before income tax (benefit) expense	(17,061)	307
Income tax (benefit) expense	(2,238)	155
Net (loss) income	$ (14,823)	$ 152
Net (loss) income per share - Basic (in dollars per share)	$ (0.84)	$ 0.01
Net (loss) income per share - Diluted (in dollars per share)	$ (0.84)	$ 0.01
Weighted average shares - Basic (in shares)	17,616,964	17,280,365
Weighted average shares - Diluted (in shares)	17,616,964	17,868,816
Selling, general and administrative	$ 36,324	$ 41,020
Product
Sales	56,525	71,577
Cost of Sales	23,066	27,951
Service
Sales	22,990	22,040
Cost of Sales	$ 12,576	$ 12,647

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Comprehensive Income [Abstract]
Net (loss) income	$ (14,823)	$ 152
Currency translation adjustments, net of income taxes	(3,778)	(1,564)
Comprehensive loss	$ (18,601)	$ (1,412)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating activities:
Net (loss) income	$ (14,823)	$ 152
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	3,759	4,749
Stock-based compensation	2,178	2,564
Provisions for bad debts, net of recoveries	(15)	(100)
Loss on disposal of assets	10	57
Provision for excess and obsolete inventory	204	896
Deferred income tax benefit	(2,326)	8
Decrease (Increase) in:
Accounts receivable	16,084	12,410
Inventories	1,795	(10,908)
Prepaid expenses and other current assets	7,408	4,463
(Decrease) Increase in:
Accounts payable and accrued liabilities	4,756	(9,172)
Income taxes payable	(1,389)	(1,323)
Net cash provided by operating activities	16,315	5,810
Investing activities:
Purchases of property and equipment	(757)	(1,543)
Proceeds from sale of investments	9,000	0
Payments for intangible assets	(435)	(529)
Net cash provided by (used in) investing activities	7,808	(2,072)
Financing activities:
Payments on finance leases	(82)	(90)
Payments of contingent consideration for acquisitions	0	(250)
Payments for taxes related to net share settlement of equity awards	(1,581)	(1,138)
Proceeds from issuance of stock related to stock option exercises	2,802	292
Net cash provided by (used in) financing activities	1,139	(1,186)
Effect of exchange rate changes on cash and cash equivalents	(1,656)	(639)
Increase in cash and cash equivalents	23,606	1,913
Cash and cash equivalents, beginning of period	133,634	108,783
Cash and cash equivalents, end of period	157,240	110,696
Customer deposits
(Decrease) Increase in:
Increase (decrease) in contract with customer, liability	(961)	(310)
Current portion of unearned service revenues
(Decrease) Increase in:
Increase (decrease) in contract with customer, liability	$ (365)	$ 2,324

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Common Stock in Treasury
Beginning Balance (in shares) at Dec. 31, 2018		17,253,011
Beginning Balance at Dec. 31, 2018	$ 376,609	$ 19	$ 251,329	$ 175,353	$ (18,483)	$ (31,609)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	152			152
Currency translation adjustment	(1,564)				(1,564)
Stock-based compensation	2,564		2,564
Common stock issued, net of shares withheld for employee taxes (in shares)		64,864
Common stock issued, net of shares withheld for employee taxes	(846)		(1,053)			207
Ending Balance (in shares) at Mar. 31, 2019		17,317,875
Ending Balance at Mar. 31, 2019	$ 376,588	$ 19	252,840	175,178	(20,047)	(31,402)
Beginning Balance (in shares) at Dec. 31, 2019	17,576,618	17,576,618
Beginning Balance at Dec. 31, 2019	$ 331,992	$ 19	267,868	112,879	(17,399)	(31,375)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(14,823)			(14,823)
Currency translation adjustment	(3,778)				(3,778)
Stock-based compensation	2,178		2,178
Common stock issued, net of shares withheld for employee taxes (in shares)		141,561
Common stock issued, net of shares withheld for employee taxes	$ 1,221		894			327
Ending Balance (in shares) at Mar. 31, 2020	18,988,379	17,718,179
Ending Balance at Mar. 31, 2020	$ 316,790	$ 19	$ 270,940	$ 98,056	$ (21,177)	$ (31,048)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Description of Business

3 Months Ended

Mar. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Business

DESCRIPTION OF BUSINESS

FARO Technologies, Inc. and its subsidiaries (collectively “FARO,” the “Company,” “us,” “we” or “our”) design, develop, manufacture, market and support software driven, three-dimensional (“3D”) measurement and imaging solutions. This technology permits high-precision 3D measurement, imaging and comparison of parts and complex structures within production and quality assurance processes. Our devices are used for inspection of components and assemblies, rapid prototyping, reverse engineering, documenting large volume or structures in 3D, surveying and construction, as well as for investigation and reconstruction of accident sites or crime scenes. We sell the majority of our products through a direct sales force across a broad number of customers in a range of manufacturing, industrial, architecture, surveying, building information modeling, construction, public safety forensics, cultural heritage, and other applications. Our FaroArm^®, FARO ScanArm^®, FARO Laser Tracker^TM, FARO Laser Projector, and their companion CAM2^®, BuildIT, and BuildIT Projectorsoftware solutions, provide for Computer-Aided Design (“CAD”) based inspection, factory-level statistical process control, high-density surveying, and laser-guided assembly and production. Together, these products integrate the measurement, quality inspection, and reverse engineering functions with CAD and 3D software to improve productivity, enhance product quality, and decrease rework and scrap in the manufacturing process, mainly supporting applications in the automotive, aerospace, metal and machine fabrication and other industrial manufacturing markets. Our FARO Focus and FARO ScanPlan, and their companion FARO SCENE, BuildIT, FARO As-Built^TM, and FARO Zone public safety forensics software offerings, are utilized for a wide variety of 3D modeling, documentation and high-density surveying applications primarily in the architecture, engineering and construction and public safety markets. Our FARO ScanArm^®and its companion SCENE software also enable a fully digital workflow used to capture real world geometry for the purpose of empowering design, enabling innovation, and speeding up the design cycle.

Since the fourth quarter of 2016 to the fourth quarter of 2019, we had operated in five verticals—3D Manufacturing, Construction Building Information Modeling (“Construction BIM”), Public Safety Forensics, 3D Design and Photonics—and had three reporting segments—3D Manufacturing, Construction BIM and Emerging Verticals. As discussed in our Quarterly Report on Form 10-Q for the third quarter of 2019, our new management team, led by our new Chief Executive Officer (“CEO”), formulated and began to implement a new comprehensive strategic plan for our business. As part of our strategic planning process, we identified areas of our business that needed enhanced focus or change in order to improve our efficiency and cost structure. In the fourth quarter of 2019, we reassessed and redefined our go-to-market strategy, refocused our marketing engagement with our customers and re-evaluated our hardware product portfolio.

As part of our new strategic plan, and based on the recommendation of our CEO, who is also our Chief Operating Decision Maker (“CODM”), in the fourth quarter of 2019, we eliminated our vertical structure and began reorganizing the Company into a functional structure. Our executive leadership team is now comprised of functional leaders in areas such as sales, marketing, operations, research and development and general and administrative, and resources are allocated to each function at a consolidated unit level. We no longer have separate business units, or segment managers or vertical leaders who report to the CODM with respect to operations, operating results or planning for levels or components below the total Company level. Instead, our CODM now allocates resources and evaluates performance on a Company-wide basis. Based on these changes, commencing with the fourth quarter of 2019, we are now reporting as one reporting segment that develops, manufactures, markets, supports and sells CAD-based quality assurance products integrated with CAD-based inspection and statistical process control software and 3D documentation systems. Our reporting segment sells into a variety of end markets, including automotive, aerospace, metal and machine fabrication, architecture, engineering, construction and public safety.

Reclassification and Related Changes to Presentation

Certain prior year amounts have been reclassified in the accompanying consolidated financial statements to conform to the current period presentation:

•Commencing with the third quarter of 2019, depreciation and amortization expenses are being reported in the accompanying statements of operations to reflect departmental costs. Previously, those expenses were reported as a separate line item under operating expenses. Amounts related to depreciation and amortization expenses for the three months ended March 31, 2019 have been reclassified throughout this Quarterly Report on Form 10-Q to reflect this reclassification of depreciation and amortization expenses and to conform to the current period presentation, as set forth in the following table;

•Selling and marketing expenses and general and administrative expenses are now being reported in the accompanying statements of operations together in one line as Selling, general and administrative. Previously, those expenses were reported as two separate line items under operating expenses. Amounts related to selling, general and administrative expenses for the three months ended March 31, 2019 have been reclassified throughout this Quarterly Report on Form 10-Q to reflect this reclassification of selling, general and administrative expenses and to conform to the current period presentation, as set forth in the following table;

•Software maintenance revenue is now being reported in the accompanying statements of operations as a component of product sales. Previously, these revenues were reported in service sales. Amounts related to software maintenance revenue for the three months ended March 31, 2019 have been reclassified throughout this Quarterly Report on Form 10-Q to reflect this reclassification of software maintenance revenue and to conform to the current period presentation, as set forth in the following table; and

•Software maintenance cost of sales is now being reported in the accompanying statements of operations as a component of product cost of sales. Previously, these cost of sales was reported in service cost of sales. Amounts related to software maintenance cost of sales for the three months ended March 31, 2019 have been reclassified throughout this Quarterly Report on Form 10-Q to reflect this reclassification of software maintenance cost of sales and to conform to the current period presentation, as set forth in the following table.


For the three months ended, March 31, 2019
	As Reported		Depreciation and Amortization Adjustment		Selling, General and Administrative Adjustment		Software Maintenance and Other Adjustments		As Adjusted
Sales
Product	$	68,800	$	—	$	—	$	2,777	$	71,577
Service	24,817		—		—		(2,777)		22,040
Total sales	$	93,617	$	—	$	—	$	—	$	93,617

Cost of Sales
Product	$	26,128	$	1,176	$	—	$	647	$	27,951
Service	12,470		824		—		(647)		12,647
Total cost of sales	$	38,598	$	2,000	$	—	$	—	$	40,598

Operating Expenses
Selling, general and administrative	$	—	$	1,043	$	39,977	$	—	$	41,020
Selling and marketing	26,753		—		(26,753)		—		—
General and administrative	13,224		—		(13,224)		—		—
Depreciation and amortization	4,749		(4,749)		—		—		—
Research and development	9,935		1,706		—		—		11,641
Total operating expenses	$	54,661	$	(2,000)	$	—	$	—	$	52,661

Principles of Consolidation	3 Months Ended
Principles of Consolidation	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Principles of Consolidation	PRINCIPLES OF CONSOLIDATIONOur condensed consolidated financial statements include the accounts of FARO Technologies, Inc. and its subsidiaries, all of which are wholly-owned. All intercompany transactions and balances have been eliminated. The financial statements of our foreign subsidiaries are translated into U.S. dollars using exchange rates in effect at period-end for assets and liabilities and average exchange rates during each reporting period for results of operations. Adjustments resulting from financial statement translations are reflected as a separate component of accumulated other comprehensive loss. Foreign currency transaction gains and losses are included in net (loss) income.

Basis of Presentation	3 Months Ended
Basis of Presentation	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements and notes thereto have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions of Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These condensed consolidated financial statements include all normal recurring accruals and adjustments considered necessary by management for a fair presentation in conformity with U.S. GAAP. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates. The condensed consolidated results of operations for the three months ended March 31, 2020 are not necessarily indicative of results that may be expected for the year ending December 31, 2020 or any future period. The information included in this Quarterly Report on Form 10-Q, including the interim condensed consolidated financial statements and the accompanying notes, should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019. The accompanying December 31, 2019 condensed consolidated balance sheet has been derived from those audited consolidated financial statements. As described in Note 1 – Description of Business, commencing with the third quarter of 2019, depreciation and amortization expenses are being reported in the accompanying statements of operations to reflect departmental costs. Previously, those expenses were reported as a separate line item under operating expenses. Amounts related to depreciation and amortization expenses for the three months ended March 31, 2020 have been reclassified throughout this Quarterly Report on Form 10-Q to reflect this reclassification of depreciation and amortization expenses and to conform to the current period presentation.

Impact of Recently Issued Accounting Pronouncements	3 Months Ended
Impact of Recently Issued Accounting Pronouncements	Mar. 31, 2020
Accounting Changes and Error Corrections [Abstract]
Impact of Recently Issued Accounting Pronouncements	IMPACT OF RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS Impact of Recently Issued Accounting Standards In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes which amends and aims to simplify accounting disclosure requirements regarding a number of topics including: intraperiod tax allocation, accounting for deferred taxes when there are changes in consolidation of certain investments, tax basis step up in an acquisition and the application of effective rate changes during interim periods, amongst other improvements. This standard is effective for fiscal years beginning after December 15, 2020 and allows for early adoption. We are currently assessing the impact of this new standard on our condensed consolidated financial statements. Impact of Recently Adopted Accounting Standards In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842) (“ASU 2016-02”), which is intended to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements to enable users of financial statements to assess the amount, timing and uncertainty of cash flows arising from leases. ASU No. 2018-11, Leases (Topic 842): Targeted Improvements, was issued by the FASB in July 2018 and allows for a cumulative-effect adjustment transition method of adoption. The new guidance is effective for fiscal years beginning after December 15, 2018 and interim periods within those years. We adopted ASU 2016-02 effective as of January 1, 2019 utilizing the cumulative-effect adjustment transition method of adoption, which resulted in the recognition on our condensed consolidated balance sheet as of March 31, 2019 of $18.9 million of right-of-use assets for operating leases, $19.9 million of lease liability for operating leases, $0.9 million of property and equipment, net for finance leases and $0.9 million of lease liability for finance leases under which we function as a lessee. We elected certain practical expedients available under the transition provisions to (i) allow aggregation of non-lease components with the related lease components when evaluating accounting treatment, (ii) apply the modified retrospective adoption method, utilizing the simplified transition option, which allows us to continue to apply the legacy guidance in FASB ASC Topic 840, including its disclosure requirements, in the comparative periods presented in the year of adoption, and (iii) use hindsight in determining the lease term (that is, when considering our options to extend or terminate the lease and to purchase the underlying asset) and in assessing impairment of our right-of-use assets. The adoption of ASU 2016-02 also required us to include any initial direct costs, which are incremental costs that would not have been incurred had the lease not been obtained, in the right-of-use assets. The recognition of these costs in connection with our adoption of this guidance did not have a material impact on our condensed consolidated financial statements. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. ASU 2016-13, and subsequent related amendments to ASU 2016-13, replaced the existing incurred loss impairment model with an expected loss model that requires the use of forward-looking information to calculate credit loss estimates. It also eliminates the concept of other-than-temporary impairment and requires credit losses related to available-for-sale debt securities to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. These changes will result in earlier recognition of credit losses. We performed an analysis to identify the Company's financial instruments which would be impacted by the promulgated amendment and identified both our trade receivables and our U.S. Treasury Bill investments. We adopted ASU 2016-13 prospectively, effective January 1, 2020, by evaluating the qualitative and quantitative characteristics of our credit-based customer portfolio. We extend credit to a customer based on an evaluation of the customer’s financial condition and, generally, collateral is not required. Trade receivables are generally due within 30 to 90 days and accounts outstanding longer than the contractual payment terms are considered past due. As part of our analysis, we calculated an allowance for all trade receivables based on our review of historical trends and future expectations for the regions we sell within, current outstanding customer balances, and the length of time balances have been outstanding. We also evaluated an allowance for our U.S. Treasury Bill investments but as they are low risk and short-term, these allowances were approximated to be zero. The adoption of ASU 2016-13 did not have a material impact on our condensed consolidated financial statements. In January 2017, the FASB issued ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (“ASU 2017-04”), which is intended to simplify the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. Under the current guidance, performance of Step 2 requires us to calculate the implied fair value of goodwill by following procedures that would be required to determine the fair value of assets acquired and liabilities assumed in a business combination. Under the new guidance, we will perform our goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge will be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value up to the amount of the goodwill allocated to the reporting unit. The new guidance also eliminates the requirements for any reporting unit with a zero or negative carrying amount to perform Step 2 of the goodwill impairment test if it fails the qualitative assessment. As a result, all reporting units will be subject to the same impairment assessment. We will still have the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. We early adopted this guidance in fiscal 2019. The adoption of ASU 2017-04 did not did not have a material impact on our condensed consolidated financial statements.

Revenues

3 Months Ended

Mar. 31, 2020

Revenue from Contract with Customer [Abstract]

Revenues

REVENUES

The following tables present our revenues by sales type as presented in our condensed consolidated statements of operations disaggregated by the timing of transfer of goods or services (in thousands, unaudited):


	For the Three Months Ended March 31,
	2020		2019
Product sales
Product transferred to customers at a point in time	$	53,554	$	68,975
Product transferred to customers over time	2,971		2,603
	$	56,525	$	71,578


	For the Three Months Ended March 31,
	2020		2019
Service sales
Service transferred to customers at a point in time	$	10,996	$	11,680
Service transferred to customers over time	11,994		10,359
	$	22,990	$	22,039

The following table presents our revenues disaggregated by geography, based on the billing addresses of our customers (in thousands, unaudited):


	For the Three Months Ended March 31,
	2020		2019
Total sales to external customers
United States	$	33,091	$	35,848
EMEA ⁽¹⁾	23,690		31,100
Other APAC ⁽¹⁾	15,487		15,042
China	4,748		8,295
Other Americas ⁽¹⁾	2,499		3,332
	$	79,515	$	93,617

⁽¹⁾Regions represent Europe, the Middle East, and Africa (EMEA); Asia-Pacific, excluding China (Other APAC); and Canada, Mexico, and Brazil (Other Americas).

For revenue related to our measurement and imaging equipment and related software, we allocate the contract price to performance obligations based on our best estimate of the standalone selling price. We make this allocation estimate utilizing data from the sale of our applicable products and services to customers separately in similar circumstances, with the exception of software licenses. With respect to software licenses, we use the residual method for allocating the contract price to performance obligations. Revenue related to our measurement and imaging equipment and related software is generally recognized upon shipment from our facilities or when delivered to the customer location, as determined by the agreed upon shipping terms, at which time we are entitled to payment and title and control has passed to the customer. Software arrangements generally include short-term maintenance that is considered post-contract support (“PCS”), which is considered to be a separate performance obligation. We generally establish a standalone sales price for this PCS component based on our maintenance renewal rate. Maintenance renewals, when sold, are recognized on a straight-line basis over the term of the maintenance agreement. Payments for products and services are collected within a short period of time following transfer of control or commencement of delivery of services, as applicable.

Further, customers frequently purchase extended warranties with the purchase of measurement equipment and related software. Warranties are considered a performance obligation when services are transferred to a customer over time, and, as such, we recognize revenue on a straight-line basis over the warranty term. Extended warranty sales primarily include contract periods that extend between one month and three years.

We capitalize commission expenses related to deliverables transferred to a customer over time and amortize such costs ratably over the term of the contract. As of March 31, 2020, the deferred cost asset related to deferred commissions was approximately $3.0 million. For classification purposes, $2.0 million and $1.0 million are comprised within the Prepaid expenses and other current assets and Other long-term assets, respectively, on our condensed consolidated balance sheet as of March 31, 2020. As of December 31, 2019, the deferred cost asset related to deferred commissions was approximately $3.1 million. For classification purposes, $2.1 million and $1.0 million were comprised within the Prepaid expenses and other current assets and Other long-term assets, respectively, on our condensed consolidated balance sheet as of December 31, 2019.

The unearned service revenue liabilities reported on our condensed consolidated balance sheets reflect the contract liabilities to satisfy the remaining performance obligations for extended warranties and software maintenance. The current portion of unearned service revenues on our condensed consolidated balance sheets is what we expect to recognize to revenue within twelve months after the applicable balance sheet date relating to extended warranty and software maintenance contract liabilities. The unearned service revenues - less current portion on our condensed consolidated balance sheets is what we expect to recognize to revenue extending beyond twelve months after the applicable balance sheet date relating to extended warranty and software maintenance contract liabilities. During the three months ended March 31, 2020, we recognized $12.2 million of revenue that was deferred on our condensed consolidated balance sheet as of December 31, 2019. During the three months ended March 31, 2019, we recognized $10.8 million of revenue that was deferred on our consolidated balance sheet as of December 31, 2018.

The nature of certain of our contracts gives rise to variable consideration, which may be constrained, primarily related to an allowance for sales returns and contracts with certain government customers. We are required to estimate the contract asset related to sales returns and record a corresponding adjustment to Cost of Sales. Our allowance for sales returns was approximately $0.1 million as of both March 31, 2020 and March 31, 2019.

Shipping and handling fees billed to customers in a sales transaction are recorded in Product Sales and shipping and handling costs incurred are recorded in Cost of Sales. We exclude from Sales any value-added sales and other taxes that we collect concurrently with revenue-producing activities.

Stock-Based Compensation

3 Months Ended

Mar. 31, 2020

Share-based Payment Arrangement [Abstract]

Stock-Based Compensation

STOCK-BASED COMPENSATION

Stock-based compensation expense reflects the fair value of stock-based awards measured at the grant date. For awards with only a service condition, we expense stock-based compensation using the straight-line method over the requisite service period for the entire award. For awards with both performance and service conditions, we expense the stock-based compensation on a straight-line basis over the requisite service period taking into account the probability that we will satisfy the performance condition.

We have two compensation plans that provide for the granting of stock options and other share-based awards to key employees and non-employee members of the Board of Directors (the “Board”). The 2009 Equity Incentive Plan (the “2009 Plan”) and the 2014 Equity Incentive Plan (the “2014 Plan”) provide for granting options, restricted stock, restricted stock units or stock appreciation rights to employees and non-employee directors. In May 2018, our shareholders approved an amendment to the 2014 Plan, which increased the number of shares available for issuance under the 2014 Plan by 1,000,000 shares. A maximum of 2,974,543 shares are available for issuance under the 2014 Plan, as amended, plus the number of shares (not to exceed 891,960) that were underlying awards outstanding under the 2004 Equity Incentive Plan (the “2004 Plan”) and the 2009 Plan as of May 29, 2014 that thereafter terminate or expire unexercised or are canceled, forfeited or lapse for any reason. No awards were outstanding under the 2004 Plan as of March 31, 2020, and no further grants will be made under the 2004 Plan or the 2009 Plan.

Upon election to the Board, each non-employee director receives an initial equity grant of shares of restricted common stock with a value equal to $100,000, calculated using the closing price of our common stock on the date of the non-employee director’s election to the Board. The initial restricted stock grant vests on the third anniversary of the grant date, subject to the non-employee director’s continued membership on the Board. Annually, the non-employee directors are granted restricted shares with a value equal to $100,000 on the first business day following the annual meeting of shareholders, calculated using the closing price of our common stock on that day. In addition, the independent Chairman of the Board is annually granted restricted shares with a value equal to $50,000, and the Lead Director, if one has been appointed, would be annually granted restricted shares with a value of $40,000, on the first business day following the annual meeting of shareholders, calculated using the closing price of our common stock on that day. The shares of restricted stock granted annually to our non-employee directors, our independent Chairman of the Board and, if applicable, our Lead Director vest on the day prior to the following year’s annual meeting date, subject to the non-employee director’s continued membership on the Board. We record compensation expense associated with our restricted stock grants on a straight-line basis over the vesting term. Also, beginning in October 2018, our non-employee directors may elect to have their annual cash retainers and annual equity retainers paid in the form of deferred stock units pursuant to the 2014 Plan and the 2018 Non-Employee Director Deferred Compensation Plan. Each deferred stock unit represents the right to receive one share of our common stock upon the non-employee director’s separation of service from the Company. We record compensation expense associated with our deferred stock units over the period of service.

Annually, upon approval by our Compensation Committee, we grant stock-based awards, which historically have been in the form of stock options and/or restricted stock units, to certain employees. We also grant stock-based awards, which historically have been in the form of stock options and/or restricted stock units, to certain new employees throughout the year. The fair value of these stock-based awards is determined by using (a) the current market price of our common stock on the grant date in the case of restricted stock units without a market condition, (b) the Monte Carlo Simulation valuation model in the case of performance-based restricted stock units with a market condition, or (c) the Black-Scholes option valuation model in the case of stock options.

Our annual grants in both February 2020 and 2019 consisted of performance-based restricted stock units and time-based restricted stock units. The number of restricted stock units granted was based on the employee’s individual objectives, performance against operational metrics assigned to the employee and overall contribution to the Company over the last year.

For the stock-based awards granted in 2020 and 2019, the time-based restricted stock units vest in three equal annual installments beginning one year after the grant date. The performance-based restricted stock unit awards vest at the end of the 3-year performance period if the applicable performance measure is achieved. The related stock-based compensation expense will be recognized over the requisite service period, taking into account the probability that we will satisfy the performance measure. The performance-based restricted stock units granted in 2020 and 2019 will be earned and will vest based upon our total shareholder return (“TSR”) relative to the TSR attained by companies within our defined benchmark group, the Russell 2000 Growth Index. Due to the TSR presence in these performance-based restricted stock units, the fair value of these awards was determined using the Monte Carlo Simulation valuation model. We expense these market condition awards over the three-year vesting period regardless of the value the award recipients ultimately receive.

The Monte Carlo Simulation valuation models incorporate assumptions as to stock price volatility, the expected life of options or awards, a risk-free interest rate and dividend yield. The weighted-average grant-date fair value of the performance-based restricted stock units that were granted during the three months ended March 31, 2020 and valued using the Monte Carlo Simulation valuation model was $80.38. The weighted-average grant-date fair value of the performance-based restricted stock units that were granted during the three months ended March 31, 2019 and valued using the Monte Carlo Simulation valuation model was $62.74. For performance-based restricted stock units granted during the three months ended March 31, 2020 valued using the Monte Carlo Simulation valuation model, we used the following assumptions:


	Three Months Ended		Three Months Ended
	March 31, 2020		March 31, 2019
Risk-free interest rate	1.16	%	2.48	%
Expected dividend yield	—	%	—	%
Term	3 years		3 years
Expected volatility	40.0	%	45.0	%
Weighted-average expected volatility	40.0	%	45.0	%

The following table summarizes stock option activity and weighted-average exercise prices during the three months ended March 31, 2020:


	Options	Weighted- Average Exercise Price		Weighted-Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value as of March 31, 2020
Outstanding at January 1, 2020	486,682	$	52.37
Granted	—	—
Forfeited or expired	(9,740)	50.74
Exercised	(57,180)	39.18
Outstanding at March 31, 2020	419,762	$	54.20	3.2	$	1,000
Options exercisable at March 31, 2020	408,489	$	54.00	2.0	$	1,000

The total intrinsic value of stock options exercised during the three months ended March 31, 2020 and March 31, 2019 was $1.0 million and $0.1 million, respectively. The fair value of stock options vested during the three months ended March 31, 2020 and March 31, 2019 was $0.8 million and $2.7 million, respectively.

The following table summarizes the restricted stock and restricted stock unit activity and weighted average grant-date fair values for the three months ended March 31, 2020:


	Shares	Weighted-Average Grant Date Fair Value
Non-vested at January 1, 2020	398,318	$	49.53
Granted	167,161	66.77
Forfeited	(16,449)	48.67
Vested	(125,399)	39.16
Non-vested at March 31, 2020	423,631	$	59.44

We recorded total stock-based compensation expense of $2.2 million and $2.6 million for the three months ended March 31, 2020 and March 31, 2019, respectively.

As of March 31, 2020, there was $20.2 million of total unrecognized stock-based compensation expense related to non-vested stock-based compensation arrangements. The expense is expected to be recognized over a weighted average period of 2.5 years.

The following table summarizes total stock-based compensation expense for each of the line items on our condensed consolidated statement of operations:


	Three Months Ended
	March 31, 2020		March 31, 2019
Cost of Sales
Product	$	154	$	153
Service	117		80
Total cost of sales	$	271	$	233
Operating Expenses
Selling, general and administrative	$	1,523	$	2,134
Research and development	382		197
Total operating expenses	$	1,905	$	2,331

Short-term Investments	3 Months Ended
Short-term Investments	Mar. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Short-term Investments	SHORT-TERM INVESTMENTSShort-term investments at March 31, 2020 were composed of U.S. Treasury Bills totaling $16.0 million maturing on June 11, 2020 carrying an interest rate of 1.4%. Short-term investments at December 31, 2019 were composed of U.S. Treasury Bills totaling $24.8 million, consisting of $8.9 million that matured on March 12, 2020 and $15.9 million maturing on June 11, 2020. The interest rates on the U.S. Treasury Bills held on December 31, 2019 that matured on March 12, 2020 and maturing on June 11, 2020 were 1.8%, and 1.4%, respectively. These investments are classified as held-to-maturity and recorded at cost plus accrued interest, which approximates fair value. We do not intend to sell these investments, and it is not more likely than not that we will be required to sell the investments before we recover their amortized cost bases.

Accounts Receivable

3 Months Ended

Mar. 31, 2020

Receivables [Abstract]

Accounts Receivable

ACCOUNTS RECEIVABLE

Accounts receivable consist of the following:


	As of March 31, 2020		As of December 31, 2019
Accounts receivable	$	62,268	$	79,611
Allowance for credit losses	(3,434)		(3,449)
Total	$	58,834	$	76,162

Inventories

3 Months Ended

Mar. 31, 2020

Inventory Disclosure [Abstract]

Inventories

INVENTORIES

Inventories are stated at the lower of cost or net realizable value using the first-in first-out (FIFO) method. We have three principal categories of inventory: 1) manufactured product to be sold; 2) sales demonstration inventory - completed product used to support our sales force for demonstrations and held for sale; and 3) service inventory - completed product and parts used to support our service department and held for sale. Shipping and handling costs are classified as a component of Cost of Sales in our condensed consolidated statements of operations. Sales demonstration inventory is held by our sales representatives for up to three years, at which time it would be refurbished and transferred to finished goods as used equipment, stated at the lower of cost or net realizable value. We expect these refurbished units to remain in finished goods inventory and sold within 12 months at prices that produce reduced gross margins. Service inventory is used to provide a temporary replacement product to a customer covered by a premium warranty when the customer’s unit requires service or repair and as training equipment. Service inventory is available for sale; however, management does not expect service inventory to be sold within 12 months and, as such, classifies this inventory as a long-term asset. Service inventory that we utilize for training or repairs and which we deem as no longer available for sale is transferred to fixed assets at the lower of cost or net realizable value and depreciated over its remaining life, typically three years.

Inventories consist of the following:


	As of March 31, 2020		As of December 31, 2019
Raw materials	$	32,659	$	36,956
Finished goods	22,385		21,598
Inventories, net	$	55,044	$	58,554

Service and sales demonstration inventory, net	$	34,355	$	33,349

(Loss) Earnings Per Share

3 Months Ended

Mar. 31, 2020

Earnings Per Share [Abstract]

(Loss) Earnings Per Share

(LOSS) EARNINGS PER SHARE

Basic (loss) earnings per share is computed by dividing net (loss) income by the weighted average number of shares outstanding. Diluted (loss) earnings per share is computed by also considering the impact of potential common stock on both net (loss) income and the weighted average number of shares outstanding. Our potential common stock consists of employee stock options, restricted stock units and performance-based awards. Our potential common stock is included in the diluted earnings per share calculation when adding such potential common stock would not be anti-dilutive. Performance-based awards are included in the computation of diluted earnings per share only to the extent that the underlying performance conditions (and any applicable market condition) (i) are satisfied as of the end of the reporting period or (ii) would be considered satisfied if the end of the reporting period were the end of the related contingency period and the result would be dilutive under the treasury stock method. When we report a net loss for the period presented, the calculation of diluted net loss per share excludes our potential common stock, as the effect would be anti-dilutive.

For the three months ended March 31, 2020, there were approximately 676,232 shares issuable upon the exercise of options and the contingent vesting of performance-based restricted stock units that were excluded from the dilutive calculations, as they were anti-dilutive. For the three ended March 31, 2019, there were approximately 372,326 issuable upon the exercise of options that were excluded from the dilutive calculations, as they were anti-dilutive.

A reconciliation of the number of common shares used in the calculation of basic and diluted loss per share is presented below:


	Three Months Ended
	March 31, 2020				March 31, 2019
	Shares	Per-Share Amount		Shares	Per-Share Amount
Basic (loss) earnings per share	17,616,964	$	(0.84)	17,280,365	$	0.01
Effect of dilutive securities	—	—		588,451	—
Diluted (loss) earnings per share	17,616,964	$	(0.84)	17,868,816	$	0.01

Accrued Liabilities

3 Months Ended

Mar. 31, 2020

Payables and Accruals [Abstract]

Accrued Liabilities

ACCRUED LIABILITIES

Accrued liabilities consist of the following:


	As of March 31, 2020		As of December 31, 2019
Accrued compensation and benefits	$	11,734	$	15,366
Accrued restructuring costs	12,761		—
Accrued warranties	2,044		2,090
Professional and legal fees	1,609		1,793
Taxes other than income	2,440		4,077
General services administration contract contingent liability (see Note 14)	12,034		11,886
Other accrued liabilities	1,738		2,860
	$	44,360	$	38,072

Activity related to accrued warranties was as follows:


	Three Months Ended
	March 31, 2020		March 31, 2019
Balance, beginning of period	$	2,090	$	2,571
Provision for warranty expense	659		878
Fulfillment of warranty obligations	(705)		(975)
Balance, end of period	$	2,044	$	2,474

Fair Value Measurements

3 Months Ended

Mar. 31, 2020

Fair Value Disclosures [Abstract]

Fair Value Measurements

FAIR VALUE MEASUREMENTS

Our financial instruments include cash and cash equivalents, short-term investments, accounts receivable, customer deposits, accounts payable and accrued liabilities. The carrying amounts of such financial instruments approximate their fair value due to the short-term nature of these instruments.

Liabilities measured at fair value on a recurring basis are categorized in the tables below based upon the lowest level of significant input to the valuations:


	As of March 31, 2020
	Level 1		Level 2		Level 3
Liabilities:
Contingent consideration ⁽¹⁾	$	—	$	—	$	733
Total	$	—	$	—	$	733
	As of December 31, 2019
	Level 1		Level 2		Level 3
Liabilities:
Contingent consideration ⁽¹⁾	$	—	$	—	$	733
Total	$	—	$	—	$	733

(1)Contingent consideration liability represents arrangements to pay the former owners of certain companies we acquired based on the former owners attaining future product release milestones and is reported in current accrued liabilities. We use a probability-weighted discounted cash flow model to estimate the fair value of contingent consideration liabilities. These probability weightings are developed internally and assessed on a quarterly basis. The remaining undiscounted maximum payment under these arrangements was $2.2 million as of March 31, 2020.

Restructuring

3 Months Ended

Mar. 31, 2020

Restructuring and Related Activities [Abstract]

Restructuring

RESTRUCTURING

In the first quarter of 2020, our Board of Directors approved a global restructuring plan (the “Restructuring Plan”), which is intended to support our strategic plan in an effort to improve operating performance and ensure that we are appropriately structured and resourced to deliver increased and sustainable value to our shareholders and customers. Key activities under the Restructuring Plan include a continued focus on efficiency and cost-saving efforts, which includes decreasing total headcount by approximately 500 employees upon the completion of the Restructuring Plan.

These activities are expected to be substantially completed by the end of 2021. In total, we estimate the implementation of the Restructuring Plan will result in first half 2020 pre-tax charges of approximately $26 million to $36 million, which are in addition to the pre-tax charges of approximately $49 million recorded in the fourth quarter of 2019 in connection with the implementation of our new strategic plan and included the following:

•$21.2 million impairment of goodwill;

•$12.8 million charge, increasing our reserve for excess and obsolete inventory;

•$10.5 million impairment of intangible assets associated with recent acquisitions;

•$1.4 million impairment of intangible assets related to capitalized patents;

•$3.4 million impairment of other assets and other charges.

In connection with the Restructuring Plan, we recorded a pre-tax charge of approximately $13.7 million during the first quarter 2020 primarily consisting of severance and related benefits. We estimate total additional pre-tax charges of $13 million to $26 million for the remainder of fiscal year 2020.

At this time, we are continuing to evaluate the future key activities by which these additional charges will originate. Actual results, including the costs of the Restructuring Plan, may differ materially from our expectations, resulting in our inability to realize the expected benefits of the Restructuring Plan and our new strategic plan and negatively impacting our ability to execute our future plans and strategies, which could have a material adverse effect on our business, financial condition and results of operations.

In connection with the Restructuring Plan, we paid $0.9 million during the first quarter 2020 primarily consisting of severance and related benefits. We expect an additional $17 million to $21 million of cash payments to be made for the remainder of fiscal year 2020 related to the Restructuring Plan. Activity related to the accrued restructuring charge and cash payments during the first quarter was as follows:


	Severance and other benefits		Professional fees and other related charges		Total
Balance at February 14, 2020	$	—	$	—	$	—
Additions charged to expense	12,956		732		13,688
Cash payments	(853)		(74)		(927)
Balance at March 31, 2020	12,103		658		12,761

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIES Purchase Commitments — We enter into purchase commitments for products and services in the ordinary course of business. These purchases generally cover production requirements for 60 to 120 days as well as materials necessary to service customer units through the product lifecycle and for warranty commitments. As of March 31, 2020, we had approximately $54.0 million in purchase commitments that are expected to be delivered within the next 12 months. Legal Proceedings — We are not involved in any legal proceedings, including routine litigation arising in the normal course of business, that we believe will have a material adverse effect on our business, financial condition or results of operations. U.S. Government Contracting Matter — We have sold our products and related services to the U.S. Government (the “Government”) under General Services Administration (“GSA”) Federal Supply Schedule contracts (the “GSA Contracts”) since 2002 and are currently selling our products and related services to the Government under two such GSA Contracts. Each GSA Contract is subject to extensive legal and regulatory requirements and includes, among other provisions, a price reduction clause (the “Price Reduction Clause”), which generally requires us to reduce the prices billed to the Government under the GSA Contracts to correspond to the lowest prices billed to certain benchmark customers. Late in the fourth quarter of 2018, during an internal review we preliminarily determined that certain of our pricing practices may have resulted in the Government being overcharged under the Price Reduction Clauses of the GSA Contracts (the “GSA Matter”). As a result, we performed remediation efforts, including but not limited to, the identification of additional controls and procedures to ensure future compliance with the pricing and other requirements of the GSA Contracts. We also retained outside legal counsel and forensic accountants to assist with these efforts and to conduct a comprehensive review of our pricing and other practices under the GSA Contracts (the “Review”). On February 14, 2019, we reported the GSA Matter to the GSA and its Office of Inspector General. As a result of the GSA Matter, for the fourth quarter 2018, we reduced our total sales by a $4.8 million estimated cumulative sales adjustment, representative of the last six years of estimated overcharges to the Government under the GSA Contracts. In addition, for the fourth quarter of 2018, we recorded $0.5 million of imputed interest related to the estimated cumulative sales adjustment, which increased Interest expense, net and resulted in an estimated total liability of $5.3 million for the GSA Matter. This adjustment was based on our preliminary review as of February 20, 2019, the date of our Annual Report on Form 10-K for the year ended December 31, 2018. In addition, in first quarter 2019, we recorded an additional $0.1 million of imputed interest related to the estimated cumulative sales adjustment. On July 15, 2019, we submitted a report to the GSA and its Office of Inspector General setting forth the findings of the Review conducted by our outside legal counsel and forensic accountants. Based on the results of the Review, we reduced our total sales for second quarter 2019 by an incremental $5.8 million sales adjustment, reflecting an estimated aggregate overcharge of $10.6 million under the GSA Contracts for the period from July 2011 to March 2019. In addition, we recorded an incremental $0.7 million of imputed interest related to the estimated cumulative sales adjustment for the remainder of 2019, which increased Interest expense, net and resulted in a $6.5 million total incremental increase in the estimated total liability for the GSA Matter. We recorded an incremental $0.1 million of imputed interest related to the estimated cumulative sales adjustment for the first quarter of 2020. As of the date of the filing of this Quarterly Report on Form 10-Q, we have recorded an aggregate estimated total liability for the GSA Matter of $12.0 million. In January 2020, we received requests for additional information from the GSA and its Office of Inspector General, and we are working with the GSA in responding to such inquiries. We intend to cooperate fully with this and any other Government inquiries. The Government’s review of, or investigation into, this matter could result in civil and criminal penalties, administrative sanctions, and contract remedies being imposed on us, including but not limited to, termination of the GSA Contracts, repayments of amounts already received under the GSA Contracts, forfeiture of profits, damages, suspension of payments, fines, and suspension or debarment from doing business with the Government and possibly U.S. state and local governments. We may also be subject to litigation and recovery under the federal False Claims Act and possibly similar state laws, which could include claims for treble damages, penalties, fees and costs. As a result, we cannot reasonably predict the outcome of the Government’s review of, or investigation into, this matter at this time or the resulting future financial impact on us. Any of these outcomes could have a material adverse effect on our reputation, our sales, results of operations, cash flows and financial condition, and the trading price of our common stock. In addition, we have incurred, and will continue to incur, legal and related costs in connection with the Review and the Government’s response to this matter.

Leases

3 Months Ended

Mar. 31, 2020

Leases [Abstract]

Leases

LEASES

We have operating and finance leases for manufacturing facilities, corporate offices, research and development facilities, sales and training facilities, vehicles, and certain equipment under which we assume the role of lessee. We do not lease assets as a lessor. Our leases have remaining lease terms of less than one year to approximately seven years, some of which include options to extend the leases for up to eight years, and some of which include options to terminate the leases within three months. We currently do not sublease any of our leased assets.

We determine if an arrangement is a lease at inception. Operating leases are included in Operating lease right-of-use (“ROU”) asset, Lease liability, and Lease liability - less current portion in our condensed consolidated balance sheets. Finance leases are included in Property and equipment, net, Lease liability, and Lease liability - less current portion in our condensed consolidated balance sheets.

ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and lease liabilities are recognized on the commencement date of the lease based on the present value of lease payments over the lease term. Variable lease payments that depend on an index or rate include the variable portion when calculating ROU assets and lease liabilities. Variable lease payments that do not depend on an index or rate are expensed as incurred. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available on the commencement date of the lease to determine the present value of lease payments. We use the implicit rate when readily determinable. The operating lease ROU assets also include any lease payments made and lease incentives. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option at the time the lease is commenced. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

While we have lease agreements with lease and non-lease components, we account for the lease and non-lease components as a single lease component.

The components of lease expense were as follows:


	Three Months Ended March 31, 2020		Three Months Ended March 31, 2019
Operating lease cost	$	2,055	$	1,969

Finance lease cost:
Amortization of ROU assets	$	82	$	92
Interest on lease liabilities	$	9	$	12
Total finance lease cost	$	91	$	104

We recognize lease payments made for short-term leases where terms are 12 months or less as the payments are incurred. Our short-term lease cost for the three months ended March 31, 2020 and March 31, 2019 was less than $0.1 million and $0.1 million, respectively.

Supplemental balance sheet information related to leases was as follows:


	As of			As of
	March 31, 2020			December 31, 2019
Operating leases:
Operating lease right-of-use asset	$	16,534		$	18,418

Current operating lease liability	$	5,617		$	6,349
Operating lease liability - less current portion	12,382			13,272
Total operating lease liability	$	17,999		$	19,621

Finance leases:
Property and equipment, at cost	$	1,553		$	1,870
Accumulated depreciation	(890)			(1,150)
Property and equipment, net	$	663		$	720

Current finance lease liability	$	330		$	325
Finance lease liability - less current portion	363			426
Total finance lease liability	$	693		$	751

Weighted Average Remaining Lease Term (in years):
Operating leases	4.42			4.48
Finance leases	2.36			2.48

Weighted Average Discount Rate:
Operating leases	5.28		%	5.10		%
Finance leases	5.06		%	5.09		%

Supplemental cash flow information related to leases was as follows:


	Three Months Ended March 31, 2020		Three Months Ended March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	2,098	$	2,029
Operating cash flows from finance leases	$	9	$	12
Financing cash flows from finance leases	$	82	$	90

ROU assets obtained in exchange for lease obligations:
Operating leases	$	395	$	5,400

Maturities of lease liabilities are as follows:


Year Ending December 31,	Operating leases		Finance leases
2020 (excluding the first 3 months)	$	5,270	$	269
2021	4,012		320
2022	3,139		93
2023	2,829		43
2024	2,700		12
Thereafter	2,354		—
Total lease payments	$	20,304	$	737
Less imputed interest	(2,305)		(44)
Total	$	17,999	$	693

Leases

LEASES

While we have lease agreements with lease and non-lease components, we account for the lease and non-lease components as a single lease component.

The components of lease expense were as follows:


	Three Months Ended March 31, 2020		Three Months Ended March 31, 2019
Operating lease cost	$	2,055	$	1,969

Finance lease cost:
Amortization of ROU assets	$	82	$	92
Interest on lease liabilities	$	9	$	12
Total finance lease cost	$	91	$	104

Supplemental balance sheet information related to leases was as follows:


	As of			As of
	March 31, 2020			December 31, 2019
Operating leases:
Operating lease right-of-use asset	$	16,534		$	18,418

Current operating lease liability	$	5,617		$	6,349
Operating lease liability - less current portion	12,382			13,272
Total operating lease liability	$	17,999		$	19,621

Finance leases:
Property and equipment, at cost	$	1,553		$	1,870
Accumulated depreciation	(890)			(1,150)
Property and equipment, net	$	663		$	720

Current finance lease liability	$	330		$	325
Finance lease liability - less current portion	363			426
Total finance lease liability	$	693		$	751

Weighted Average Remaining Lease Term (in years):
Operating leases	4.42			4.48
Finance leases	2.36			2.48

Weighted Average Discount Rate:
Operating leases	5.28		%	5.10		%
Finance leases	5.06		%	5.09		%

Supplemental cash flow information related to leases was as follows:


	Three Months Ended March 31, 2020		Three Months Ended March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	2,098	$	2,029
Operating cash flows from finance leases	$	9	$	12
Financing cash flows from finance leases	$	82	$	90

ROU assets obtained in exchange for lease obligations:
Operating leases	$	395	$	5,400

Maturities of lease liabilities are as follows:


Year Ending December 31,	Operating leases		Finance leases
2020 (excluding the first 3 months)	$	5,270	$	269
2021	4,012		320
2022	3,139		93
2023	2,829		43
2024	2,700		12
Thereafter	2,354		—
Total lease payments	$	20,304	$	737
Less imputed interest	(2,305)		(44)
Total	$	17,999	$	693

Subsequent Events	3 Months Ended
Subsequent Events	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTS We are significantly vulnerable to the economic effects of pandemics and other public health crises, including the ongoing novel coronavirus (“COVID-19”) outbreak that has surfaced in every country of our global operating footprint. We are not able to forecast the impact that COVID-19 will have on our revenues, operations, business and financial position due to many uncertainties. We will continue to assess the impact of COVID-19, including future events and developments, such as the duration and magnitude of the outbreak, impact on our suppliers and customers, the demand for our products and services, and whether the pandemic leads to recessionary conditions in any of our key markets.

Principles of Consolidation (Policies)	3 Months Ended
Principles of Consolidation (Policies)	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Consolidation	Our condensed consolidated financial statements include the accounts of FARO Technologies, Inc. and its subsidiaries, all of which are wholly-owned. All intercompany transactions and balances have been eliminated.
Foreign Currency Translation	The financial statements of our foreign subsidiaries are translated into U.S. dollars using exchange rates in effect at period-end for assets and liabilities and average exchange rates during each reporting period for results of operations. Adjustments resulting from financial statement translations are reflected as a separate component of accumulated other comprehensive loss. Foreign currency transaction gains and losses are included in net (loss) income.
Basis of Presentation	The accompanying unaudited condensed consolidated financial statements and notes thereto have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) for interim financial information and with the instructions of Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These condensed consolidated financial statements include all normal recurring accruals and adjustments considered necessary by management for a fair presentation in conformity with U.S. GAAP.
Use of Estimates	Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.
Impact of Recently Adopted and Recently Issued Accounting Standards	Impact of Recently Issued Accounting Standards In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes which amends and aims to simplify accounting disclosure requirements regarding a number of topics including: intraperiod tax allocation, accounting for deferred taxes when there are changes in consolidation of certain investments, tax basis step up in an acquisition and the application of effective rate changes during interim periods, amongst other improvements. This standard is effective for fiscal years beginning after December 15, 2020 and allows for early adoption. We are currently assessing the impact of this new standard on our condensed consolidated financial statements. Impact of Recently Adopted Accounting Standards In February 2016, the FASB issued Accounting Standards Update (“ASU”) No. 2016-02, Leases (Topic 842) (“ASU 2016-02”), which is intended to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements to enable users of financial statements to assess the amount, timing and uncertainty of cash flows arising from leases. ASU No. 2018-11, Leases (Topic 842): Targeted Improvements, was issued by the FASB in July 2018 and allows for a cumulative-effect adjustment transition method of adoption. The new guidance is effective for fiscal years beginning after December 15, 2018 and interim periods within those years. We adopted ASU 2016-02 effective as of January 1, 2019 utilizing the cumulative-effect adjustment transition method of adoption, which resulted in the recognition on our condensed consolidated balance sheet as of March 31, 2019 of $18.9 million of right-of-use assets for operating leases, $19.9 million of lease liability for operating leases, $0.9 million of property and equipment, net for finance leases and $0.9 million of lease liability for finance leases under which we function as a lessee. We elected certain practical expedients available under the transition provisions to (i) allow aggregation of non-lease components with the related lease components when evaluating accounting treatment, (ii) apply the modified retrospective adoption method, utilizing the simplified transition option, which allows us to continue to apply the legacy guidance in FASB ASC Topic 840, including its disclosure requirements, in the comparative periods presented in the year of adoption, and (iii) use hindsight in determining the lease term (that is, when considering our options to extend or terminate the lease and to purchase the underlying asset) and in assessing impairment of our right-of-use assets. The adoption of ASU 2016-02 also required us to include any initial direct costs, which are incremental costs that would not have been incurred had the lease not been obtained, in the right-of-use assets. The recognition of these costs in connection with our adoption of this guidance did not have a material impact on our condensed consolidated financial statements. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost. ASU 2016-13, and subsequent related amendments to ASU 2016-13, replaced the existing incurred loss impairment model with an expected loss model that requires the use of forward-looking information to calculate credit loss estimates. It also eliminates the concept of other-than-temporary impairment and requires credit losses related to available-for-sale debt securities to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. These changes will result in earlier recognition of credit losses. We performed an analysis to identify the Company's financial instruments which would be impacted by the promulgated amendment and identified both our trade receivables and our U.S. Treasury Bill investments. We adopted ASU 2016-13 prospectively, effective January 1, 2020, by evaluating the qualitative and quantitative characteristics of our credit-based customer portfolio. We extend credit to a customer based on an evaluation of the customer’s financial condition and, generally, collateral is not required. Trade receivables are generally due within 30 to 90 days and accounts outstanding longer than the contractual payment terms are considered past due. As part of our analysis, we calculated an allowance for all trade receivables based on our review of historical trends and future expectations for the regions we sell within, current outstanding customer balances, and the length of time balances have been outstanding. We also evaluated an allowance for our U.S. Treasury Bill investments but as they are low risk and short-term, these allowances were approximated to be zero. The adoption of ASU 2016-13 did not have a material impact on our condensed consolidated financial statements. In January 2017, the FASB issued ASU No. 2017-04, Intangibles - Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (“ASU 2017-04”), which is intended to simplify the subsequent measurement of goodwill by eliminating Step 2 from the goodwill impairment test. Under the current guidance, performance of Step 2 requires us to calculate the implied fair value of goodwill by following procedures that would be required to determine the fair value of assets acquired and liabilities assumed in a business combination. Under the new guidance, we will perform our goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An impairment charge will be recognized for the amount by which the carrying amount exceeds the reporting unit’s fair value up to the amount of the goodwill allocated to the reporting unit. The new guidance also eliminates the requirements for any reporting unit with a zero or negative carrying amount to perform Step 2 of the goodwill impairment test if it fails the qualitative assessment. As a result, all reporting units will be subject to the same impairment assessment. We will still have the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. We early adopted this guidance in fiscal 2019. The adoption of ASU 2017-04 did not did not have a material impact on our condensed consolidated financial statements.
Inventory	Inventories are stated at the lower of cost or net realizable value using the first-in first-out (FIFO) method. We have three principal categories of inventory: 1) manufactured product to be sold; 2) sales demonstration inventory - completed product used to support our sales force for demonstrations and held for sale; and 3) service inventory - completed product and parts used to support our service department and held for sale. Shipping and handling costs are classified as a component of Cost of Sales in our condensed consolidated statements of operations. Sales demonstration inventory is held by our sales representatives for up to three years, at which time it would be refurbished and transferred to finished goods as used equipment, stated at the lower of cost or net realizable value. We expect these refurbished units to remain in finished goods inventory and sold within 12 months at prices that produce reduced gross margins. Service inventory is used to provide a temporary replacement product to a customer covered by a premium warranty when the customer’s unit requires service or repair and as training equipment. Service inventory is available for sale; however, management does not expect service inventory to be sold within 12 months and, as such, classifies this inventory as a long-term asset. Service inventory that we utilize for training or repairs and which we deem as no longer available for sale is transferred to fixed assets at the lower of cost or net realizable value and depreciated over its remaining life, typically three years.

Description of Business (Tables)

3 Months Ended

Mar. 31, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Error Corrections and Prior Period Adjustments


For the three months ended, March 31, 2019
	As Reported		Depreciation and Amortization Adjustment		Selling, General and Administrative Adjustment		Software Maintenance and Other Adjustments		As Adjusted
Sales
Product	$	68,800	$	—	$	—	$	2,777	$	71,577
Service	24,817		—		—		(2,777)		22,040
Total sales	$	93,617	$	—	$	—	$	—	$	93,617

Cost of Sales
Product	$	26,128	$	1,176	$	—	$	647	$	27,951
Service	12,470		824		—		(647)		12,647
Total cost of sales	$	38,598	$	2,000	$	—	$	—	$	40,598

Operating Expenses
Selling, general and administrative	$	—	$	1,043	$	39,977	$	—	$	41,020
Selling and marketing	26,753		—		(26,753)		—		—
General and administrative	13,224		—		(13,224)		—		—
Depreciation and amortization	4,749		(4,749)		—		—		—
Research and development	9,935		1,706		—		—		11,641
Total operating expenses	$	54,661	$	(2,000)	$	—	$	—	$	52,661

Revenues (Tables)

3 Months Ended

Mar. 31, 2020

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue


	For the Three Months Ended March 31,
	2020		2019
Product sales
Product transferred to customers at a point in time	$	53,554	$	68,975
Product transferred to customers over time	2,971		2,603
	$	56,525	$	71,578


	For the Three Months Ended March 31,
	2020		2019
Service sales
Service transferred to customers at a point in time	$	10,996	$	11,680
Service transferred to customers over time	11,994		10,359
	$	22,990	$	22,039

The following table presents our revenues disaggregated by geography, based on the billing addresses of our customers (in thousands, unaudited):


	For the Three Months Ended March 31,
	2020		2019
Total sales to external customers
United States	$	33,091	$	35,848
EMEA ⁽¹⁾	23,690		31,100
Other APAC ⁽¹⁾	15,487		15,042
China	4,748		8,295
Other Americas ⁽¹⁾	2,499		3,332
	$	79,515	$	93,617

⁽¹⁾Regions represent Europe, the Middle East, and Africa (EMEA); Asia-Pacific, excluding China (Other APAC); and Canada, Mexico, and Brazil (Other Americas).

Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2020

Share-based Payment Arrangement [Abstract]

Schedule of Valuation Assumptions

For performance-based restricted stock units granted during the three months ended March 31, 2020 valued using the Monte Carlo Simulation valuation model, we used the following assumptions:


	Three Months Ended		Three Months Ended
	March 31, 2020		March 31, 2019
Risk-free interest rate	1.16	%	2.48	%
Expected dividend yield	—	%	—	%
Term	3 years		3 years
Expected volatility	40.0	%	45.0	%
Weighted-average expected volatility	40.0	%	45.0	%

Schedule of Stock Option Activity and Weighted Average Exercise Prices

The following table summarizes stock option activity and weighted-average exercise prices during the three months ended March 31, 2020:


	Options	Weighted- Average Exercise Price		Weighted-Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value as of March 31, 2020
Outstanding at January 1, 2020	486,682	$	52.37
Granted	—	—
Forfeited or expired	(9,740)	50.74
Exercised	(57,180)	39.18
Outstanding at March 31, 2020	419,762	$	54.20	3.2	$	1,000
Options exercisable at March 31, 2020	408,489	$	54.00	2.0	$	1,000

Schedule of Restricted Stock and Restricted Stock Units Activity and Weighted-Average Grant Date Fair Value

The following table summarizes the restricted stock and restricted stock unit activity and weighted average grant-date fair values for the three months ended March 31, 2020:


	Shares	Weighted-Average Grant Date Fair Value
Non-vested at January 1, 2020	398,318	$	49.53
Granted	167,161	66.77
Forfeited	(16,449)	48.67
Vested	(125,399)	39.16
Non-vested at March 31, 2020	423,631	$	59.44

Share-based Payment Arrangement, Expensed and Capitalized, Amount

The following table summarizes total stock-based compensation expense for each of the line items on our condensed consolidated statement of operations:


	Three Months Ended
	March 31, 2020		March 31, 2019
Cost of Sales
Product	$	154	$	153
Service	117		80
Total cost of sales	$	271	$	233
Operating Expenses
Selling, general and administrative	$	1,523	$	2,134
Research and development	382		197
Total operating expenses	$	1,905	$	2,331

Accounts Receivable (Tables)

3 Months Ended

Mar. 31, 2020

Receivables [Abstract]

Schedule of Accounts Receivable

Accounts receivable consist of the following:


	As of March 31, 2020		As of December 31, 2019
Accounts receivable	$	62,268	$	79,611
Allowance for credit losses	(3,434)		(3,449)
Total	$	58,834	$	76,162

Financing Receivable, Allowance for Credit Loss

Activity related to the allowance for credit losses was as follows:


	Three Months Ended March 31, 2020
Beginning balance of the allowance for credit losses	$	(3,449)
Current period provision for expected credit losses	(608)
Recoveries of amounts previously written off	623
Ending balance of the allowance for credit losses	$	(3,434)

Inventories (Tables)

3 Months Ended

Mar. 31, 2020

Inventory Disclosure [Abstract]

Schedule of Inventory

Inventories consist of the following:


	As of March 31, 2020		As of December 31, 2019
Raw materials	$	32,659	$	36,956
Finished goods	22,385		21,598
Inventories, net	$	55,044	$	58,554

Service and sales demonstration inventory, net	$	34,355	$	33,349

Earnings (Loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2020

Earnings Per Share [Abstract]

Reconciliation of Number of Common Shares Used in Calculation of Basic and Diluted Earnings Per Share (EPS)

A reconciliation of the number of common shares used in the calculation of basic and diluted loss per share is presented below:


	Three Months Ended
	March 31, 2020				March 31, 2019
	Shares	Per-Share Amount		Shares	Per-Share Amount
Basic (loss) earnings per share	17,616,964	$	(0.84)	17,280,365	$	0.01
Effect of dilutive securities	—	—		588,451	—
Diluted (loss) earnings per share	17,616,964	$	(0.84)	17,868,816	$	0.01

Accrued Liabilities (Tables)

3 Months Ended

Mar. 31, 2020

Payables and Accruals [Abstract]

Schedule of Accrued Liabilities

Accrued liabilities consist of the following:


	As of March 31, 2020		As of December 31, 2019
Accrued compensation and benefits	$	11,734	$	15,366
Accrued restructuring costs	12,761		—
Accrued warranties	2,044		2,090
Professional and legal fees	1,609		1,793
Taxes other than income	2,440		4,077
General services administration contract contingent liability (see Note 14)	12,034		11,886
Other accrued liabilities	1,738		2,860
	$	44,360	$	38,072

Schedule of Activity Related to Accrued Warranties

Activity related to accrued warranties was as follows:


	Three Months Ended
	March 31, 2020		March 31, 2019
Balance, beginning of period	$	2,090	$	2,571
Provision for warranty expense	659		878
Fulfillment of warranty obligations	(705)		(975)
Balance, end of period	$	2,044	$	2,474

Fair Value of Financial Measurements (Tables)

3 Months Ended

Mar. 31, 2020

Fair Value Disclosures [Abstract]

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Liabilities measured at fair value on a recurring basis are categorized in the tables below based upon the lowest level of significant input to the valuations:


	As of March 31, 2020
	Level 1		Level 2		Level 3
Liabilities:
Contingent consideration ⁽¹⁾	$	—	$	—	$	733
Total	$	—	$	—	$	733
	As of December 31, 2019
	Level 1		Level 2		Level 3
Liabilities:
Contingent consideration ⁽¹⁾	$	—	$	—	$	733
Total	$	—	$	—	$	733

Restructuring and Related Activities (Tables)

3 Months Ended

Mar. 31, 2020

Restructuring and Related Activities [Abstract]

Restructuring and Related Costs


	Severance and other benefits		Professional fees and other related charges		Total
Balance at February 14, 2020	$	—	$	—	$	—
Additions charged to expense	12,956		732		13,688
Cash payments	(853)		(74)		(927)
Balance at March 31, 2020	12,103		658		12,761

Leases (Tables)

3 Months Ended

Mar. 31, 2020

Leases [Abstract]

Lease cost and Supplemental Cash Flow Information Related to Leases

The components of lease expense were as follows:


	Three Months Ended March 31, 2020		Three Months Ended March 31, 2019
Operating lease cost	$	2,055	$	1,969

Finance lease cost:
Amortization of ROU assets	$	82	$	92
Interest on lease liabilities	$	9	$	12
Total finance lease cost	$	91	$	104

Supplemental cash flow information related to leases was as follows:


	Three Months Ended March 31, 2020		Three Months Ended March 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	2,098	$	2,029
Operating cash flows from finance leases	$	9	$	12
Financing cash flows from finance leases	$	82	$	90

ROU assets obtained in exchange for lease obligations:
Operating leases	$	395	$	5,400

Supplemental Balance Sheet Information Related to Leases

Supplemental balance sheet information related to leases was as follows:


	As of			As of
	March 31, 2020			December 31, 2019
Operating leases:
Operating lease right-of-use asset	$	16,534		$	18,418

Current operating lease liability	$	5,617		$	6,349
Operating lease liability - less current portion	12,382			13,272
Total operating lease liability	$	17,999		$	19,621

Finance leases:
Property and equipment, at cost	$	1,553		$	1,870
Accumulated depreciation	(890)			(1,150)
Property and equipment, net	$	663		$	720

Current finance lease liability	$	330		$	325
Finance lease liability - less current portion	363			426
Total finance lease liability	$	693		$	751

Weighted Average Remaining Lease Term (in years):
Operating leases	4.42			4.48
Finance leases	2.36			2.48

Weighted Average Discount Rate:
Operating leases	5.28		%	5.10		%
Finance leases	5.06		%	5.09		%

Lessee, Operating Lease, Liability, Maturity

Maturities of lease liabilities are as follows:


Year Ending December 31,	Operating leases		Finance leases
2020 (excluding the first 3 months)	$	5,270	$	269
2021	4,012		320
2022	3,139		93
2023	2,829		43
2024	2,700		12
Thereafter	2,354		—
Total lease payments	$	20,304	$	737
Less imputed interest	(2,305)		(44)
Total	$	17,999	$	693

Finance Lease, Liability, Maturity

Maturities of lease liabilities are as follows:


Year Ending December 31,	Operating leases		Finance leases
2020 (excluding the first 3 months)	$	5,270	$	269
2021	4,012		320
2022	3,139		93
2023	2,829		43
2024	2,700		12
Thereafter	2,354		—
Total lease payments	$	20,304	$	737
Less imputed interest	(2,305)		(44)
Total	$	17,999	$	693

Description of Business (Details) $ in Thousands	3 Months Ended		48 Months Ended
Description of Business (Details) $ in Thousands	Mar. 31, 2020 USD ($) segment	Mar. 31, 2019 USD ($)	Dec. 31, 2019 segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reportable segments \| segment	1		5
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Sales	$ 79,515	$ 93,617
Cost of Sales	35,642	40,598
Selling, general and administrative	36,324	41,020
Selling and marketing		0
General and administrative		0
Depreciation and amortization		0
Research and development	10,415	11,641
Total operating expenses	60,427	52,661
Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Sales		93,617
Cost of Sales		38,598
Selling, general and administrative		0
Selling and marketing		26,753
General and administrative		13,224
Depreciation and amortization		4,749
Research and development		9,935
Total operating expenses		54,661
Restatement Adjustment \| Depreciation and Amortization Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cost of Sales		2,000
Selling, general and administrative		1,043
Selling and marketing		0
General and administrative		0
Depreciation and amortization		(4,749)
Research and development		1,706
Total operating expenses		(2,000)
Restatement Adjustment \| Selling, General and Administrative Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Selling, general and administrative		39,977
Selling and marketing		(26,753)
General and administrative		(13,224)
Depreciation and amortization		0
Research and development		0
Total operating expenses		0
Restatement Adjustment \| Software Maintenance and Other Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Sales		0
Cost of Sales		0
Product
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Sales	56,525	71,577
Cost of Sales	23,066	27,951
Product \| Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Sales		68,800
Cost of Sales		26,128
Product \| Restatement Adjustment \| Depreciation and Amortization Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cost of Sales		1,176
Product \| Restatement Adjustment \| Software Maintenance and Other Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Sales		2,777
Cost of Sales		647
Service
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Sales	22,990	22,040
Cost of Sales	$ 12,576	12,647
Service \| Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Sales		24,817
Cost of Sales		12,470
Service \| Restatement Adjustment \| Depreciation and Amortization Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cost of Sales		824
Service \| Restatement Adjustment \| Software Maintenance and Other Adjustments
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Sales		(2,777)
Cost of Sales		$ (647)

Impact of Recently Issued Accounting Pronouncements - Additional Information (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Jan. 01, 2019
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Operating lease right-of-use asset	$ 16,534	$ 18,418
Operating lease liability	$ 17,999	$ 19,621
Accounting Standards Update 2016-02
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Operating lease right-of-use asset			$ 18,900
Operating lease liability			19,900
Accounting Standards Update 2016-02 \| Property, Plant and Equipment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Operating lease liability			900
Accounting Standards Update 2016-02 \| Finance Leases
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Operating lease liability			$ 900

Revenues - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Sales	$ 79,515	$ 93,617
United States
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Sales	33,091	35,848
EMEA
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Sales	23,690	31,100
Other APAC
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Sales	15,487	15,042
China
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Sales	4,748	8,295
Other Americas
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Sales	2,499	3,332
Product sales
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Sales	56,525	71,578
Product sales \| Product transferred to customers at a point in time
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Sales	53,554	68,975
Product sales \| Product transferred to customers over time
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Sales	2,971	2,603
Service sales
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Sales	22,990	22,039
Service sales \| Product transferred to customers at a point in time
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Sales	10,996	11,680
Service sales \| Product transferred to customers over time
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Sales	$ 11,994	$ 10,359

Revenues - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
Revenues - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Disaggregation of Revenue [Line Items]
Recognized service revenue	$ 12.2	$ 10.8
Refund liability	0.1	$ 0.1
Commissions
Disaggregation of Revenue [Line Items]
Capitalized contract cost, gross	3.0		$ 3.1
Prepaid expenses and other current assets \| Commissions
Disaggregation of Revenue [Line Items]
Capitalized contract cost, gross	2.0		2.1
Other long-term assets \| Commissions
Disaggregation of Revenue [Line Items]
Capitalized contract cost, gross	$ 1.0		$ 1.0

Stock-Based Compensation - Additional Information (Details)	1 Months Ended	3 Months Ended
	May 31, 2018 shares	Mar. 31, 2020 USD ($) plan $ / shares shares	Mar. 31, 2019 USD ($) $ / shares	Dec. 31, 2019 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of compensation plans \| plan		2
Total intrinsic value of stock options exercised		$ 1,000,000.0	$ 100,000
Fair value of stock options vested		800,000	2,700,000
Allocated share-based compensation expense		$ 1,905,000	$ 2,331,000
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average fair value (USD per share) \| $ / shares		$ 59.44		$ 49.53
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period		3 years
Weighted average fair value (USD per share) \| $ / shares		$ 80.38	$ 62.74
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares outstanding (in shares) \| shares		419,762		486,682
Restricted Stock and Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense		$ 2,200,000	$ 2,600,000
Unrecognized stock-based compensation expense		$ 20,200,000
Weighted average, expected recognition period		2 years 6 months
2014 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Additional shares authorized (in shares) \| shares	1,000,000
Shares authorized (in shares) \| shares	2,974,543
Shares outstanding (in shares) \| shares		0
2004 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized (in shares) \| shares	891,960
Directors Plan \| Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term for value of shares to be granted upon election		$ 100,000
Directors Plan \| Restricted Stock \| Independent Chairman of the Board
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term for value of shares to be granted upon election		50,000
Directors Plan \| Restricted Stock \| Lead Director
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Term for value of shares to be granted upon election		$ 40,000

Stock-Based Compensation - Assumptions Used to Estimate The Fair Value of Time-Based Stock Options (Details)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Term	3 years	3 years
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Risk-free interest rate	1.16%	2.48%
Expected dividend yield	0.00%	0.00%
Expected volatility	40.00%	45.00%
Weighted-average expected volatility	40.00%	45.00%

Stock-Based Compensation - Schedule of Stock Option Activity and Weighted Average Exercise Prices (Details) - Employee Stock Option $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2020 USD ($) $ / shares shares
Options
Beginning balance (in shares) \| shares	486,682
Granted (in shares) \| shares	0
Forfeited or expired (in shares) \| shares	(9,740)
Exercised (in shares) \| shares	(57,180)
Ending balance (in shares) \| shares	419,762
Options exercisable at September 30, 2019 (in shares) \| shares	408,489
Weighted- Average Exercise Price
Beginning balance (in dollars per share) \| $ / shares	$ 52.37
Granted (in dollars per share) \| $ / shares	0
Forfeited or expired (in dollars per share) \| $ / shares	50.74
Exercised (in dollars per share) \| $ / shares	39.18
Ending balance (in dollars per share) \| $ / shares	54.20
Options exercisable at September 30, 2019 (in dollars per share) \| $ / shares	$ 54.00
Weighted-Average Remaining Contractual Term (Years)
Weighted-average remaining contractual term, outstanding at September 30, 2019	3 years 2 months 12 days
Weighted-average remaining contractual term, options exercisable at September 30, 2019	2 years
Aggregate Intrinsic Value as of March 31, 2020
Aggregate intrinsic value outstanding at September 30, 2019 \| $	$ 1,000
Aggregate intrinsic value of options exercisable at September 30, 2019 \| $	$ 1,000

Stock-Based Compensation - Schedule of Restricted Stock Unit Activity and Weighted Average Grant Date Fair Value (Details) - Restricted Stock Units	3 Months Ended
	Mar. 31, 2020 $ / shares shares
Shares
Non-vested, beginning balance (in shares) \| shares	398,318
Granted (in shares) \| shares	167,161
Forfeited (in shares) \| shares	(16,449)
Vested (in shares) \| shares	(125,399)
Non-vested, ending balance (in shares) \| shares	423,631
Weighted-Average Grant Date Fair Value
Non-vested, beginning balance (in dollars per share) \| $ / shares	$ 49.53
Granted (in dollars per share) \| $ / shares	66.77
Forfeited (in dollars per share) \| $ / shares	48.67
Vested (in dollars per share) \| $ / shares	39.16
Non-vested, ending balance (in dollars per share) \| $ / shares	$ 59.44

Stock-Based Compensation - Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Allocated share-based compensation expense	$ 1,905	$ 2,331
Cost of Sales
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Allocated share-based compensation expense	271	233
Cost of Sales \| Product
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Allocated share-based compensation expense	154	153
Cost of Sales \| Service
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Allocated share-based compensation expense	117	80
Selling and Marketing Expense
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Allocated share-based compensation expense	1,523	2,134
Research and Development Expense
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Allocated share-based compensation expense	$ 382	$ 197

Short-term Investments - Narrative (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Securities Purchased Under Agreements to Resell and Other Short Term Investment Securities [Line Items]
Short-term investments	$ 15,955	$ 24,870
US Treasury Bill Securities
Securities Purchased Under Agreements to Resell and Other Short Term Investment Securities [Line Items]
Short-term investments	$ 16,000	24,800
Interest rate on U.S. Treasury Bills	1.40%
U.S. Treasury Security, Maturing on March 12, 2020 \| US Treasury Bill Securities
Securities Purchased Under Agreements to Resell and Other Short Term Investment Securities [Line Items]
Short-term investments		$ 8,900
Interest rate on U.S. Treasury Bills		1.80%
U.S. Treasury Security, Maturing on June 11, 2020 \| US Treasury Bill Securities
Securities Purchased Under Agreements to Resell and Other Short Term Investment Securities [Line Items]
Short-term investments		$ 15,900
Interest rate on U.S. Treasury Bills		1.40%

Accounts Receivable - Additional Information (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Receivables [Abstract]
Accounts receivable	$ 62,268	$ 79,611
Allowance for credit losses	(3,434)	(3,449)
Total	$ 58,834	$ 76,162

Accounts Receivable - Credit Loss (Details) $ in Thousands	3 Months Ended
Accounts Receivable - Credit Loss (Details) $ in Thousands	Mar. 31, 2020 USD ($)
Receivables [Abstract]
Beginning balance of the allowance for credit losses	$ (3,449)
Current period provision for expected credit losses	(608)
Recoveries of amounts previously written off	623
Ending balance of the allowance for credit losses	$ (3,434)

Inventories - Additional Information (Details)	3 Months Ended
Inventories - Additional Information (Details)	Mar. 31, 2020
Property, Plant and Equipment [Line Items]
Demonstration inventory shelf life (in years)	3 years
Refurbished demonstration inventory selling period (in months)	12 months
Service Inventory
Property, Plant and Equipment [Line Items]
Inventory, remaining useful life (in years)	3 years

Inventories - Schedule of Inventory (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 32,659	$ 36,956
Finished goods	22,385	21,598
Inventories, net	55,044	58,554
Service and sales demonstration inventory, net	$ 34,355	$ 33,349

(Loss) Earnings Per Share - Reconciliation of Number of Common Shares Used in Calculation of Basic and Diluted Earnings Per Share (EPS) (Details) - $ / shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Earnings Per Share [Abstract]
Antidilutive securities (in shares)	676,232	372,326
Earnings Per Share, Basic and Diluted [Abstract]
Basic (loss) earnings per share (in shares)	17,616,964	17,280,365
Effect of dilutive securities (in shares)	0	588,451
Diluted (loss) earnings (in shares)	17,616,964	17,868,816
Basic (loss) earnings (in dollars per share)	$ (0.84)	$ 0.01
Effect of dilutive securities (in dollars per share)	0	0
Diluted (loss) earnings (in dollars per share)	$ (0.84)	$ 0.01

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

+ Details

Accrued Liabilities - Summary (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Payables and Accruals [Abstract]
Accrued compensation and benefits	$ 11,734	$ 15,366
Accrued restructuring costs	12,761	0
Accrued warranties	2,044	2,090	$ 2,474	$ 2,571
Professional and legal fees	1,609	1,793
Taxes other than income	2,440	4,077
General services administration contract contingent liability (see Note 14)	12,034	11,886
Other accrued liabilities	1,738	2,860
Accrued liabilities	$ 44,360	$ 38,072

Accrued Liabilities - Activity Related to Accrued Warranties (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]
Balance, beginning of period	$ 2,090	$ 2,571
Provision for warranty expense	659	878
Fulfillment of warranty obligations	(705)	(975)
Balance, end of period	$ 2,044	$ 2,474

Fair Value Measurements - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Liabilities:
Payment of contingent consideration for acquisitions	$ 0	$ 250
Level 1 \| Fair Value, Measurements, Recurring
Liabilities:
Contingent consideration	0		$ 0
Total	0		0
Level 2 \| Fair Value, Measurements, Recurring
Liabilities:
Contingent consideration	0		0
Total	0		0
Level 3 \| Fair Value, Measurements, Recurring
Liabilities:
Contingent consideration	733		733
Total	733		$ 733
Monte Carlo Simulation Valuation Model
Liabilities:
Undiscounted maximum payment under the contingent consideration arrangements	$ 2,200

Restructuring - Narrative (Details) $ in Thousands		2 Months Ended	3 Months Ended
Restructuring - Narrative (Details) $ in Thousands	Feb. 14, 2020 USD ($) headcount	Mar. 31, 2020 USD ($)	Mar. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Mar. 31, 2019 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring costs			$ 13,688		$ 0
Professional fees and other related charges
Restructuring Cost and Reserve [Line Items]
Expected number of positions eliminated \| headcount	500
Incurred cost			13,700	$ 49,000
Professional fees and other related charges \| Goodwill
Restructuring Cost and Reserve [Line Items]
Restructuring costs				21,200
Professional fees and other related charges \| Excess and Obsolete Inventory
Restructuring Cost and Reserve [Line Items]
Restructuring costs				12,800
Professional fees and other related charges \| Acquired Assets
Restructuring Cost and Reserve [Line Items]
Restructuring costs				10,500
Professional fees and other related charges \| Capitalized Patents
Restructuring Cost and Reserve [Line Items]
Restructuring costs				1,400
Professional fees and other related charges \| Other Assets
Restructuring Cost and Reserve [Line Items]
Restructuring costs				$ 3,400
Professional fees and other related charges \| Minimum
Restructuring Cost and Reserve [Line Items]
Expected cost	$ 26,000	$ 13,000	13,000
Restructuring and related cost, cash	17,000
Professional fees and other related charges \| Maximum
Restructuring Cost and Reserve [Line Items]
Expected cost	36,000	26,000	$ 26,000
Restructuring and related cost, cash	$ 21,000
Employee Severance
Restructuring Cost and Reserve [Line Items]
Payments for restructuring		$ 900

Restructuring - Activity (Details) - USD ($) $ in Thousands	2 Months Ended	3 Months Ended
Restructuring - Activity (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Mar. 31, 2020	Mar. 31, 2019
Restructuring Cost and Reserve [Line Items]
Additions charged to expense		$ 13,688	$ 0
Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Balance at February 14, 2020	$ 0
Additions charged to expense	13,688
Cash payments	(927)
Balance at March 31, 2020	12,761	12,761
Severance and other benefits \| Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Balance at February 14, 2020	0
Additions charged to expense	12,956
Cash payments	(853)
Balance at March 31, 2020	12,103	12,103
Professional fees and other related charges \| Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Balance at February 14, 2020	0
Additions charged to expense	732
Cash payments	(74)
Balance at March 31, 2020	$ 658	$ 658

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended				12 Months Ended	72 Months Ended	93 Months Ended
	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Mar. 31, 2019
Commitments and Contingencies [Line Items]
Purchase commitment, due in next twelve months	$ 54.0
Minimum
Commitments and Contingencies [Line Items]
Length of purchase commitments, (in days)	60 days
Maximum
Commitments and Contingencies [Line Items]
Length of purchase commitments, (in days)	120 days
Government Contract
Commitments and Contingencies [Line Items]
Charges to income from price adjustment clauses						$ 4.8
GSA matter and imputed interest	$ 0.1		$ 0.1	$ 0.5	$ 0.7
Total estimated liability from price adjustment clauses	$ 12.0			$ 5.3		$ 5.3
Reduction in sales, adjustment		$ 5.8
Estimated aggregate overcharge in contracts							$ 10.6
Other Expense \| Government Contract
Commitments and Contingencies [Line Items]
Total estimated liability from price adjustment clauses		$ 6.5

Leases - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
Leases - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2020	Mar. 31, 2019
Lessee, Lease, Description [Line Items]
Renewal term	8 years
Termination window	3 months
Short term lease cost	$ 0.1	$ 0.1
Minimum
Lessee, Lease, Description [Line Items]
Term of contract	1 year
Maximum
Lessee, Lease, Description [Line Items]
Term of contract	7 years

Leases - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended
Leases - Lease Cost (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Mar. 31, 2019
Leases [Abstract]
Operating lease cost	$ 2,055	$ 1,969
Finance lease cost:
Amortization of ROU assets	82	92
Interest on lease liabilities	9	12
Total finance lease cost	$ 91	$ 104

Leases Supplemental Balance Sheet Information Related to Leases (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Operating leases:
Operating lease right-of-use asset	$ 16,534	$ 18,418
Current operating lease liability	5,617	6,349
Operating lease liability - less current portion	12,382	13,272
Total operating lease liability	17,999	19,621
Finance leases:
Property and equipment, at cost	1,553	1,870
Accumulated depreciation	(890)	(1,150)
Property and equipment, net	663	720
Current finance lease liability	330	325
Finance lease liability - less current portion	363	426
Total finance lease liability	$ 693	$ 751
Weighted Average Remaining Lease Term (in years):
Operating leases	4 years 5 months 1 day	4 years 5 months 23 days
Finance leases	2 years 4 months 9 days	2 years 5 months 23 days
Weighted Average Discount Rate:
Operating leases	5.28%	5.10%
Finance leases	5.06%	5.09%

Leases - Supplemental Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 2,098	$ 2,029
Operating cash flows from finance leases	9	12
Financing cash flows from finance leases	82	90
ROU assets obtained in exchange for lease obligations:
Operating leases	$ 395	$ 5,400

Leases - Maturities of lease liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Operating leases
2020 (excluding the first 3 months)	$ 5,270
2021	4,012
2022	3,139
2023	2,829
2024	2,700
Thereafter	2,354
Total lease payments	20,304
Less imputed interest	(2,305)
Total	17,999	$ 19,621
Financing leases
2020 (excluding the first 3 months)	269
2021	320
2022	93
2023	43
2024	12
Thereafter	0
Total lease payments	737
Less imputed interest	(44)
Total	$ 693	$ 751

Label	Element	Value
Accounting Standards Update 2014-09 [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ (327,000)
Accounting Standards Update 2014-09 [Member] \| Retained Earnings [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ (327,000)